NL-OMON35531CompletedNot Applicable
A single-site, open-label study in healthy male subjects to compare rotigotine saliva and plasma concentrations in steady-state after multiple-dose application of rotigotine transdermal patch - Rotigotine transdermal patch study
CB Pharma0 sites14 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 14
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •male; 18 - 25 years; BMI 19.0 - 28.0 kg/m2; no smoking; white skin.
Exclusion Criteria
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 3 months the screening for the study or being a blood donor within 3 months prior to the screening for the study. In case of donating more than 1.5 liters of blood in the 10 months prior the start of this study.
Investigators
Similar Trials
Completed
Not Applicable
Single-center, open-label study in healthy male subjects to evaluate the absolute bioavailability of a 10 mg oral dose of vericiguat (BAY 1021189) (as IR tablets following a high-fat, high-calorie meal) in comparison to an intravenous, 14C-labeled micro-dose (20 µg) of vericiguat10019280heart failureNL-OMON42434Bayer HealthCare AG, Clinical Sciences10
Completed
Not Applicable
Pharmacokinetic study of fermented red ginseng extractKCT0000735Chonbuk National University Hospital12
Completed
Phase 1
An Open-label, Single-dose, Non-randomized Study of IV 14C-labeled PER977 in Healthy Male SubjectsHealthyNCT02205905Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.6
Recruiting
Not Applicable
A Single-Center, Prospective Study in Healthy Subjects to Validate a New OXYGEN RESERVE INDEX (ORI)zuurstofspanning en zuurstof saturatie bij gezonde vrijwilligersOxygen Reserve Indexpressure of O2NL-OMON41998MASIMO20
Not yet recruiting
Not Applicable
Validate a New OXYGEN RESERVE INDEX (ORI)NL-OMON20848MCG20